Tomohiro Hirose
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata.
Journal: The Journal of dermatology
Published: September 17, 2025
Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
Journal: The Journal of dermatology
Published: October 28, 2024
Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
Journal: The Journal of dermatology
Published: September 05, 2024
Laboratory markers predicting tofacitinib efficacy in Japanese patients with rheumatoid arthritis: A pooled analysis of Phase 2/3 randomised controlled clinical trials.
Journal: Modern rheumatology
Published: September 03, 2024
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib.
Journal: Modern rheumatology
Published: July 18, 2023
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
Journal: Modern rheumatology
Published: March 07, 2023
Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database.
Journal: The Journal of dermatology
Published: August 15, 2022
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment.
Journal: Rheumatology and therapy
Published: August 18, 2021
Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: A retrospective analysis of a cross-sectional questionnaire survey.
Journal: The Journal of dermatology
Published: April 23, 2021
Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy.
Journal: Arthritis research & therapy
Published: March 22, 2021
Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment With Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan.
Journal: Value in health regional issues
Published: October 30, 2020
Post-marketing surveillance of high-dose methotrexate (>8 mg/week) in Japanese patients with rheumatoid arthritis: A post hoc sub-analysis of patients according to duration of prior methotrexate use.
Journal: Modern rheumatology
Published: September 16, 2020
Last Updated: 09/26/2026